Vericel Corporation (VCEL)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Dominick C. Colangelo Esq.
|
CEO, President & Director | 1.74M | 5.37M | 1964 |
|
Mr. Joseph Anthony Mara Jr.
|
CFO & Treasurer | 854.87k | -- | 1976 |
|
Mr. Michael Halpin
|
Chief Operating Officer | 913.87k | 566.49k | 1962 |
|
Mr. Sean C. Flynn
|
Chief Legal Officer | 740.67k | -- | 1974 |
|
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.
|
Chief Medical Officer | 755.88k | 748.82k | 1962 |
|
Mr. Jonathan D. Siegal
|
Principal Accounting Officer, VP & Corporate Controller | -- | -- | -- |
|
Mr. Eric Burns
|
Vice President of Finance & Investor Relations | -- | -- | -- |
|
Mr. Roland DeAngelis
|
Chief Marketing Officer | -- | -- | -- |
|
Mr. Patrick J. Fowler
|
Senior Vice President of Corporate Development & Strategy | -- | -- | -- |
|
Mr. Mike Gilligan
|
Senior Vice President of Sales | -- | -- | -- |
Vericel Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 398
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
Corporate Governance
Upcoming Events
November 5, 2026 at 1:30 PM UTC
Vericel Corporation Earnings Date
